
Loading, please wait...

Loading, please wait...

Autosomal recessive spastic ataxia of Charlevoix-Saguenay, known as ARSACS, is an inherited neurodegenerative disease marked by ataxia, spasticity, and peripheral neuropathy. As lower-limb motor function gradually declines, affected individuals progressively transition to manual wheelchairs to maintain mobility. However, standard wheelchair provision rarely includes specialized propulsion education or structured adaptation programs. Recent evidence shows that wheelchair skills training can bridge this critical gap for affected adults. Consequently, targeted neurorehabilitation protocols offer valuable support to optimize functional autonomy and user safety.
ARSACS stems from mutations in the SACS gene, which severely impairs sacsin protein function in motor pathways. Typically, gait instability emerges in early childhood and steadily progresses alongside pyramidal spasticity and distal muscle wasting. Most individuals become wheelchair-dependent by the third or fourth decade of life. However, operating a manual wheelchair with progressive ataxia presents substantial biomechanical hurdles. Patients struggle with dysmetria, poor trunk stability, and involuntary kinetic tremors during propulsion. Furthermore, upper-extremity spasticity combined with peripheral neuropathy impairs fine hand movements needed for effective wheel gripping. When healthcare providers fail to deliver structured mobility education, users experience recurrent shoulder injuries and elevated tipping risks. In addition, persistent frustration with propulsion barriers often accelerates social isolation and physical deconditioning. Therefore, multidisciplinary rehabilitation teams must evaluate mobility limitations proactively. Early therapeutic interventions help preserve functional independence and reduce musculoskeletal strain before severe secondary complications develop.
To examine structured training efficacy, clinical researchers designed a prospective multimethod pilot study involving three adult males with ARSACS. The research team combined validated objective assessments with comprehensive qualitative interviews before and after the intervention. Specifically, investigators utilized the Wheelchair Skills Test to measure functional capacity and performance under standardized conditions. Furthermore, participants completed the Wheelchair Use Confidence Scale to assess personal self-efficacy across diverse mobility challenges. The clinical protocol consisted of five individual sessions focusing on manual propulsion mechanics, transfer safety, and obstacle navigation. In addition, experienced rehabilitation specialists tailored each session to accommodate individual motor deficits and fatigue levels. Post-intervention semi-structured interviews subsequently explored participant perspectives regarding wheelchair mobility and program satisfaction. Because rare hereditary conditions present significant recruitment hurdles, pilot designs provide vital preliminary safety and efficacy benchmarks. Consequently, this study establishes crucial empirical evidence to guide future clinical trial design in hereditary ataxias.
Following the five training sessions, all three participants demonstrated notable improvements in wheelchair skills capacity. In addition, individual scores on the Wheelchair Use Confidence Scale increased substantially across the cohort. These positive gains demonstrate that structured motor learning remains feasible despite underlying cerebellar degeneration. Through targeted repetition, participants learned energy-efficient propulsion techniques that effectively circumvent ataxia and distal muscle weakness. Moreover, acquiring reliable maneuvering strategies diminished the fear of tipping during everyday mobility tasks. Consequently, participants reported feeling far more empowered when navigating doorways, tight corners, and gentle slopes. Nevertheless, clinical analysis identified a fascinating paradox within the recorded data. Although physical capacity and user confidence improved markedly, recorded wheelchair skills performance actually decreased. This unexpected divergence highlights the critical distinction between laboratory capability and real-world behavioral execution. Rehabilitation clinicians must therefore recognize that higher clinical capacity does not automatically translate into altered daily habits.
Understanding why daily performance declined despite enhanced capacity provides invaluable lessons for neurorehabilitation practitioners. In clinical measurement, capacity reflects what an individual can accomplish in a controlled testing environment. Conversely, performance captures what a patient actually chooses to do during unmonitored daily life. During the educational sessions, participants developed a realistic understanding of environmental hazards and personal physical constraints. Consequently, this heightened awareness prompted individuals to exercise caution rather than attempting risky maneuvers outdoors without supervision. Furthermore, severe environmental barriers, such as broken pavement, steep curbs, and absent ramps, strongly discourage independent outdoor propulsion. In many instances, family members or caregivers also provide manual assistance to expedite community transit. Neuromuscular fatigue further restricts physical exertion in ARSACS, leading users to conserve physical energy for vital daily activities. Therefore, rehabilitation programs must combine clinic-based training with real-world environmental modifications to translate capacity gains into sustained community participation.
The qualitative interview findings offered powerful context regarding the emotional and psychological journey of device adoption. Prior to training, participants described difficult adaptation processes and significant anxiety surrounding manual wheelchair reliance. Many individuals initially perceived wheelchair usage as an emotional symbol of progressive functional defeat. However, post-training interviews revealed high satisfaction, improved personal morale, and renewed enthusiasm for active community mobility. Participants specifically emphasized that learning efficient propulsion ergonomics minimized upper-limb fatigue and prevented chronic shoulder strain. Furthermore, every participant strongly recommended introducing wheelchair skills training much earlier in the disease trajectory. When clinicians introduce mobility aids proactively, patients can master essential maneuvering techniques before severe ambulatory loss occurs. Consequently, early education minimizes transition trauma and prevents harmful compensatory movement habits. Neurologists should therefore normalize assistive technology discussions early in routine follow-up care. Proactive guidance empowers patients to embrace mobility devices as empowering tools rather than signs of disability.
These pilot findings offer meaningful guidance for neurologists, physiatrists, and allied health professionals managing rare neurodegenerative conditions. Although the sample size was limited to three male patients, the study confirms feasibility and notable safety. Clinicians must interpret these preliminary results cautiously until future randomized controlled trials establish definitive causality. Nevertheless, incorporating structured functional assessments like the Wheelchair Skills Test allows clinicians to quantify mobility progression objectively. In addition, physical therapists should integrate community-based obstacle training to bridge the gap between clinic capacity and daily performance. Multidisciplinary teams must also engage caregivers to promote patient autonomy and prevent unnecessary mobility assistance. In resource-diverse clinical settings, structured training programs can substantially optimize assistive device longevity and user satisfaction. Ultimately, proactive functional rehabilitation transforms palliative neurodegenerative management into an empowering therapeutic paradigm. Neurologists should routinely recommend specialized mobility training to enhance long-term independence and quality of life.
Structured wheelchair skills training boosts user confidence by teaching biomechanically efficient propulsion techniques, balance control, and safe maneuverability. Consequently, patients gain practical mastery over complex tasks such as tackling inclines and executing safe transfers. Furthermore, expert guidance diminishes the pervasive fear of falling or tipping. This enhanced sense of physical self-efficacy empowers individuals with progressive ataxia to navigate daily obstacles with significantly less psychological distress.
In clinical research, capacity measures what an individual can achieve in a controlled setting, whereas performance reflects daily community habits. Training heightened the participants' awareness of potential hazards and safety risks. Consequently, participants adopted more cautious travel behaviors outdoors. In addition, persistent architectural barriers and neuromuscular fatigue often discourage patients from utilizing newly learned advanced skills without direct supervision in real-world settings.
Rehabilitation guidelines recommend introducing manual wheelchair mobility training early in the disease course, well before complete ambulatory loss occurs. Proactive training enables patients to develop coordination and muscle memory while upper-extremity strength remains preserved. Furthermore, early familiarization normalizes assistive device adoption, significantly reducing emotional resistance and anxiety. Consequently, timely intervention ensures a smooth, safe transition when walking becomes unsafe or excessively exhausting.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A recent pilot study evaluated wheelchair skills training in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). The intervention enhanced wheelchair capacity and user confidence, emphasizing the need for targeted neurorehabilitation strategies.
Today

Tamil Nadu Kasanoi Erappila Thittam (TNKET) achieved up to a 56% drop in tuberculosis mortality by triaging adult patients with five bedside parameters at diagnosis. Published in BMJ Global Health, the ICMR-NIE evaluation demonstrates how acute inpatient admission prevents early deaths across public health systems.
Today

Adaptive spectral analysis of umbilical venous Doppler recordings reveals that an elevated second-trimester maternal-fetal power ratio can distinguish pregnancies at risk of preeclampsia, offering a novel biophysical approach to enhance early vascular risk stratification.
Today

A real-world cohort study of 6,537 patients from the FOUNTAIN platform demonstrates that initiating finerenone significantly reduces albuminuria by 40.7% with minimal eGFR decline and manageable hyperkalemia risk, confirming its practical effectiveness and safety in diabetic kidney disease.
Today

Adding a 12-week tele-supervised resistance band exercise program to intra-articular hyaluronic acid injections significantly improves physical function, chair stands, and mobility in knee osteoarthritis, despite showing no additive reduction in baseline pain scores.
Today

A secondary analysis of the OMDOT-1 trial highlights how tirzepatide and semaglutide uniquely reshape gut microbial diversity and metabolic pathways in type 2 diabetes, providing new insights into incretin-mediated metabolic regulation.
Today